Another study has demonstrated the presence of tissue transglutaminase 2 (TGM2) protein, unique to HCC cell-derived EVs, suggesting its potential as a candidate diagnostic biomarker for HCC [124]. The gene discussed is TGM2; the disease is hepatocellular carcinoma.